AngioDynamics Gains AngioVac Clot Remover In $55 Mil. Vortex Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Deal strengthens peripheral vascular product offerings with the addition of 510(k)-cleared blood clot removal system, which AngioDynamics expects will generate $50 million in annual sales in five years.